{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "regularMarketChangePercent": 22.368423, "regularMarketPrice": 0.93, "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "exchange": "STU", "shortName": "Pharnext", "longName": "Pharnext SA", "messageBoardId": "finmb_39414143", "exchangeTimezoneName": "Europe/Berlin", "marketState": "REGULAR", "firstTradeDateMilliseconds": 1541574000000, "priceHint": 4, "regularMarketChange": 0.17000002, "regularMarketTime": 1683903098, "regularMarketDayHigh": 0.93, "regularMarketDayRange": "0.8499 - 0.93", "regularMarketDayLow": 0.8499, "regularMarketVolume": 0, "regularMarketPreviousClose": 0.76, "bid": 0.88, "ask": 1.17, "bidSize": 0, "askSize": 0, "fullExchangeName": "Stuttgart", "financialCurrency": "EUR", "regularMarketOpen": 0.8499, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.17000002, "fiftyTwoWeekLowChangePercent": 0.22368424, "fiftyTwoWeekRange": "0.76 - 910000.0", "fiftyTwoWeekHighChange": -909999.06, "fiftyTwoWeekHighChangePercent": -0.999999, "fiftyTwoWeekLow": 0.76, "fiftyTwoWeekHigh": 910000.0, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -2000.0, "sharesOutstanding": 875246976, "bookValue": -678.987, "fiftyDayAverage": 1.2152, "fiftyDayAverageChange": -0.28519994, "fiftyDayAverageChangePercent": -0.23469384, "twoHundredDayAverage": 11491.334, "twoHundredDayAverageChange": -11490.404, "twoHundredDayAverageChangePercent": -0.9999191, "marketCap": 813979712, "priceToBook": -0.0013696875, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "symbol": "P0X.SG"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "9 rue des Filles Saint-Thomas", "city": "Paris", "zip": "75002", "country": "France", "phone": "33 1 41 09 22 30", "website": "https://www.pharnext.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Pharnext SA, a clinical-stage biopharmaceutical company, engages in the development of therapies for orphan and common neurodegenerative diseases in France. Its products include PXT3003, novel fixed-dose synergistic combination of baclofen, naltrexone, and sorbitol under Phase 3 development for the treatment of Charcot-Marie-Tooth Disease Type 1A; and PXT864, a novel fixed-dose synergistic combination of baclofen and acamprosate under Phase 2a development for the treatment of Alzheimer's Disease and Amyotrophic Lateral Sclerosis. The company was founded in 2007 and is headquartered in Issy-Les-Moulineaux, France.", "fullTimeEmployees": 28, "companyOfficers": [{"maxAge": 1, "name": "Mr. Daniel E. Cohen", "age": 69, "title": "Director", "yearBorn": 1953, "fiscalYear": 2016, "totalPay": {"raw": 319297, "fmt": "319.3k", "longFmt": "319,297"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Hugo  Brugiere M.Sc.", "title": "CEO & Chairman", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ilya  Chumakov Ph.D., D-Sc", "title": "Co-Founder, Chairman of Scientific Advisory Board and Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Xavier  Paoli M.Sc.", "title": "Chief Operating Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Antoine  Gravelle", "title": "Gen. Counsel", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Susanne  Dorn", "title": "Chief Regulatory Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Rodolphe  Hajj", "title": "Chief Pharmacology Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Viviane  Bertrand", "title": "Chief Preclinical Drug Devel. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Philippe  Rinaudo", "title": "Chief Data Science Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Burkhard  Blank M.D.", "age": 67, "title": "Chief Medical Officer and Head of R&D", "yearBorn": 1955, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1483142400, "maxAge": 86400}}], "error": null}}